O08.1

Clinical Causes: Abnormal clotting processes such as disseminated intravascular coagulation (DIC) following pregnancy-related tissue issues. Presence of blood clotting factor deficiencies, like afibrinogenemia, that impair normal blood clot formation. Hemolysis, or destruction of red blood cells, triggered by tissue breakdown or immune responses post-pregnancy. Incomplete or delayed expulsion of pregnancy tissue in cases of molar pregnancy or ectopic pregnancy leading to bleeding complications. Infections or inflammation that can alter blood clotting mechanisms after pregnancy events.

Key Symptoms: Heavy vaginal bleeding that may be delayed or ongoing beyond the expected timeframe. Signs of anemia such as fatigue, weakness, or pallor due to blood loss. Signs of coagulopathy, including bleeding from gums, nose, or injection sites. Fever or abdominal pain if infection or tissue necrosis occurs. Low blood pressure or dizziness indicating significant blood loss or circulatory compromise. Laboratory findings indicating abnormal blood clotting or red blood cell destruction.

Diagnosis Path: Diagnosis involves a combination of clinical evaluation, laboratory tests, and imaging studies. Blood tests such as complete blood count (CBC) and coagulation profiles help identify bleeding disorders or clotting abnormalities. Specific tests may include fibrinogen levels, D-dimer, and tests for hemolysis. Ultrasound imaging can assist in locating retained tissue or bleeding sources, particularly in the pelvis. In some cases, advanced coagulation studies or tissue biopsies may be necessary to clarify the underlying cause.

Treatment Protocols: Management of delayed or excessive hemorrhage following ectopic and molar pregnancy often involves multidisciplinary care. Treatments may include: